eli lilly & co s tirzepatide sues companies selling alternative versions of its weight loss drug Eli Lilly's tirzepatide is off

As of April 2026, FDA regulations around compounded GLP-1s have tightened significantly

Both are GLP-1 receptor agonists used for type 2 diabetes, but semaglutide is also approved for weight management and is available as a weekly injection or daily tablet, while dulaglutide is available only as a weekly injection

Semaglutide is no exception, and its important to understand the risks as well as the rewards as you consider using it to achieve your goals

Trump sees as rife in Washington, the White House has instead sought to leverage the budget as a tool to assist its allies or as a cudgel to hurt the presidents foes

This suggests that adherence and consistency are far more important than the precise hour of administration

The speed of GLP-1-induced weight loss often faster than traditional diet and exercise methods gives skin even less time to adapt naturally